Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease
- PMID: 39190826
- PMCID: PMC11785501
- DOI: 10.1080/09273948.2024.2391420
Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease
Abstract
Purpose: The choroidal thickening and serous retinal detachments that characterize Vogt-Koyanagi-Harada (VKH) disease can be imaged in detail using spectral domain optical coherence tomography (SD-OCT). Whether specific qualitative and quantitative SD-OCT features at presentation were associated with visual outcomes in a randomized controlled trial comparing methotrexate to mycophenolate for steroid-sparing control of uveitis were evaluated.
Methods: An exploratory subanalysis of data from the FAST trial in which SD-OCT images from VKH participants were analyzed for presence/absence of bacillary detachments, retinal pigment epithelium (RPE) folds, and internal limiting membrane (ILM) fluctuations was performed. A modified RPE undulation index was calculated to provide a quantifiable surrogate marker for choroidal folds.
Results: SD-OCT images were available from 158 eyes with VKH. At baseline, bacillary detachments were present in 23.5% of eyes, RPE folds in 22.8% of eyes, and ILM fluctuations in 35.2% of eyes. For each 0.1 unit increase in modified RPE undulation index, there was an associated 0.13 increase in mean logMAR BSCVA at baseline. None of the SD-OCT features were associated with BSCVA at the 6-month primary endpoint. Indeed, mean final BSCVA was similar in those with and without the SD-OCT features of interest at baseline, and was between 0.1 and 0.2 logMAR (Snellen visual acuity 20/25 to 20/30).
Conclusions: While eyes with VKH may present with a variety of SD-OCT imaging pathology prior to starting immunosuppression with methotrexate or mycophenolate mofetil, final visual outcome in our study was excellent. With appropriate immunosuppression, good visual outcomes are possible in VKH.ClinicalTrials.gov Identifier NCT01829295Date of Registration: April 11, 2013.
Keywords: Retinal pigment epithelium undulation index; SD-OCT; Vogt-Koyanagi-Harada.
Conflict of interest statement
Financial and Conflict of Interest Disclosures:
Miel Sundararajan: Nothing to disclose
Sivakumar R. Rathinam: Nothing to disclose
Radhika Thundikandy: Nothing to disclose
Anuradha Kanakath: Nothing to disclose
S. Balamurugan: Nothing to disclose
R. Vedhanayaki: Nothing to disclose
D. Claire Miller: Nothing to disclose
Lyndell L. Lim: Nothing to disclose
Eric B. Suhler: Nothing to disclose
Hassan A. Al-Dhibi: Nothing to disclose
Lourdes Arellanes-Garcia: Nothing to disclose
Amit K. Reddy: Consultant, Eyepoint
Shu Feng: Nothing to disclose
Thuy Doan: Nothing to disclose
Travis C. Porco: Nothing to disclose
Jessica G. Shantha: Nothing to disclose
Nisha Acharya: Drug donation, AbbVie; Consultant, Roche
John Gonzales: Consultant, Dompé
References
-
- O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017. Jan-Feb;62(1):1–25. - PubMed
-
- Burkholder BM. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol. 2015. Nov;26(6):506–11. - PubMed
-
- Yaqoob Z, Wu J, Yang C. Spectral domain optical coherence tomography: a better OCT imaging strategy. BioTechnique. 2005. Dec; 39:S6–S13. - PubMed
-
- Mehta N, Chong J, Tsui E, et al. Presumed foveal bacillary layer detachment in a patient with toxoplasmosis chorioretinitis and pachychoroid disease. Retin Cases Brief Rep. 2021. Jul 1;15(4):391–398. - PubMed
-
- Cicinelli MV, Giuffré C, Marchese A, et al. The bacillary detachment in posterior segment ocular diseases. Ophthalmol Retina. 2020. Apr;4(4):454–456. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous